Life Science Companies are Litigation Targets for Unhappy Investors Post author:Sam Post published:February 22, 2018 Post category:BioPharma Life science companies are popular targets for securities fraud litigation. Source: BioSpace You Might Also Like Sihuan Pharma Opens Up R&D Shop in the San Francisco Bay Area August 14, 2017 Why Bristol-Myers Squibb Could be the Answer to Pfizer's Pipeline Woes August 31, 2017 2 Biotechs With the Potential of Doubling Investors' Cash February 14, 2018
